Farah Bahrani Mougeot is a professor at the Department of Oral Medicine and Microbiome Research Laboratory, Cannon Research Center, University of North Carolina at Charlotte. She received her M.S. in Biology/Bacteriology at the University of North Carolina and her Ph.D. in Molecular Microbiology and Immunology at the University of Maryland. After her graduation, she was a Postdoctoral Fellow in Pathogen–Host Interaction at the Pasteur Institute (1995–1997) and received a European Molecular Biology Organization (EMBO) Fellowship in Cellular Microbiology (1995–1996). From 1997 to 2000, she was a Research Fellow in Bacterial Pathogenesis at the Division of Infectious Diseases and Center for Vaccine Development, School of Medicine, University of Maryland. Then, she got a certificate in Epidemiology of Pediatric Infectious Diseases from WHO (Geneva, Switzerland) in 1998 and got a NIAID/National Research Service Award (NRSA) Fellowship in Vaccinology (Bethesda, MD), 1999–2000. In 2000–2002, she was a senior scientist/group leader at Prokaria, Ltd. (Reykjavik, Iceland). Her research at the oral medicine research laboratory focuses on the discovery and characterization of both microbiomic and human genomic biomarkers for the understanding and diagnosis of several oral and systemic diseases/pathological conditions, including Sjögren’s syndrome, infective endocarditis, and cancer therapy-associated oral complications such as oral mucositis, radiation caries, and periodontal disease.
Farah Bahrani Mougeot is a professor at the Department of Oral Medicine and Microbiome Research Laboratory, Cannon Research Center, University of North Carolina at Charlotte. She received her M.S. in Biology/Bacteriology at the University of North Carolina and her Ph.D. in Molecular Microbiology and Immunology at the University of Maryland. After her graduation, she was a Postdoctoral Fellow in Pathogen–Host Interaction at the Pasteur Institute (1995–1997) and received a European Molecular Biology Organization (EMBO) Fellowship in Cellular Microbiology (1995–1996). From 1997 to 2000, she was a Research Fellow in Bacterial Pathogenesis at the Division of Infectious Diseases and Center for Vaccine Development, School of Medicine, University of Maryland. Then, she got a certificate in Epidemiology of Pediatric Infectious Diseases from WHO (Geneva, Switzerland) in 1998 and got a NIAID/National Research Service Award (NRSA) Fellowship in Vaccinology (Bethesda, MD), 1999–2000. In 2000–2002, she was a senior scientist/group leader at Prokaria, Ltd. (Reykjavik, Iceland). Her research at the oral medicine research laboratory focuses on the discovery and characterization of both microbiomic and human genomic biomarkers for the understanding and diagnosis of several oral and systemic diseases/pathological conditions, including Sjögren’s syndrome, infective endocarditis, and cancer therapy-associated oral complications such as oral mucositis, radiation caries, and periodontal disease.